- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.18 Å
- Oligo State
- monomer
- Ligands
- 1 x GLC: alpha-D-glucopyranose(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x S41: N,N-dimethyl-5-({2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl}oxy)pyrimidine-2-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pfefferkorn, J.A. et al., Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus. MEDCHEMCOMM (2011)
- Release Date
- 2011-09-14
- Peptides
- Glucokinase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A